Astrazeneca reported $39.27B in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
AstraZeneca AZN:LN 39268M 476M
Canopy Growth Corp WEED:CN C$ 4.21B 28.79M
Corcept Therapeutics CORT:US $ 375.81M 164.42M
Genmab GEN:DC DK 22719M 523M
Novartis NOVN:VX SF 67655M 10884M
Valeant Pharmaceuticals VRX:CN $ -106M 98M
Zoetis ZTS:US $ 4543M 136M